Completed
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
NCT02020889
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
- Locations
-
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Bethesda, Maryland, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site Boston, Massachusetts, United States